Is Pulmonary Rehabilitation (PR) effective in people recovering from severe COVID-19 (C-19) pneumonia?

F. Knight (Reading, United Kingdom), L. Cornish (Reading, United Kingdom), X. Shen (Reading, United Kingdom), C. Thomas (Reading, United Kingdom)

Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19
Session: Insights into rehabilitation and physiotherapy in COVID-19
Session type: E-poster
Number: 2264

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Knight (Reading, United Kingdom), L. Cornish (Reading, United Kingdom), X. Shen (Reading, United Kingdom), C. Thomas (Reading, United Kingdom). Is Pulmonary Rehabilitation (PR) effective in people recovering from severe COVID-19 (C-19) pneumonia?. 2264

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
What should Pulmonary Rehabilitation (PR) look like for people with post-tuberculosis lung disease (PTBLD) in Kyrgyzstan?
Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe
Year: 2020


The progress of BODE(survival) index by 165 patients with severe and very severe COPD (GOLD III-IV) after 3 weeks of inpatient pulmonary rehabilitation (PR)
Source: International Congress 2014 – Best posters in physical activity, exercise testing and muscles
Year: 2014


How can we increase Pulmonary Rehabilitation (PR) uptake and outcomes in COPD patients?
Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases
Year: 2019


Clinical cure rates in patients treated with azithromycin (AZ) for lower respiratory infections (LRTI) caused by AZ-susceptible (AZ-S) and AZ-resistant (AZ-R) organisms: Analysis of phase 3 clinical trials
Source: International Congress 2014 – Respiratory symptoms in primary care populations
Year: 2014


Psychological co-morbidities in patients with COPD: Which changes can be observed during inpatient pulmonary rehabilitation (PR)?
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 2
Year: 2014


Surfactant protein D (SPD) like marker of effectiveness ofphosphatidylcholine treatment outcomes in patients (pts) with community acquired pneumonia (CAP)
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015


Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013


Influence of an acute exacerbation during pulmonary rehabilitation (PR) on outcomes of PR in COPD patients awaiting lung transplantation
Source: International Congress 2014 – Latest insights in pulmonary rehabilitation
Year: 2014


Pulmonary rehabilitation (PR) capacity, uptake and completion rate in the East of England
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016


What should Pulmonary Rehabilitation (PR) look like for adults living with post-TB lung disease (PTBLD) in Kyrgyzstan? A qualitative study
Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions
Year: 2021


Maintenance strategy preferences following pulmonary rehabilitation (PR) for patients with chronic respiratory disease (CRD): A Survey
Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions
Year: 2021


Health locus of control in pulmonary rehabilitation (PR) of severe COPD patients
Source: International Congress 2016 – Latest insights into pulmonary rehabilitation
Year: 2016


Is pulmonary rehabilitation (PR) an effective therapy in lymphangioleiomyomatosis (LAM)?
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012


The role of temporary positive expiratory pressure (T-PEP) as respiratory physiotherapy technique for patient affected by non cystic fibrosis (CF) bronchiectasis
Source: International Congress 2014 – Best posters in chronic care
Year: 2014


An evaluation of outcomes for patients with pulmonary hypertension (PH) incorporated into a standard UK pulmonary rehabilitation (PR) programme
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016


The opinions of people living with chronic respiratory disease (CRD) and healthcare professionals (HCPs) about Pulmonary Rehabilitation (PR) in Kyrgyzstan.
Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe
Year: 2020


Asthma control (AC) 1 year after pulmonary rehabilitation (PR)
Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions?
Year: 2011


Pulmonary rehabilitation (PR) in adults with COPD and Heart Failure (HF); data from the UK 2015 National COPD:PR Audit
Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases
Year: 2019


Psychological comorbidities in patients with COPD: Which changes can be observed after 3, 6, 9 and 12 months of an inpatient pulmonary rehabilitation (PR)?
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015


Metabolic syndrome (MS) in COPD patients entering pulmonary rehabilitation (PR)
Source: Annual Congress 2008 - Assessing profiles of rehabilitation candidates
Year: 2008